These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 22420653)

  • 21. Direct renin inhibition: extricating facts from façades.
    Juncos L
    Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):153-67. PubMed ID: 23487045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
    Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
    Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct renin inhibitors as antihypertensive agents.
    Israili ZH; Velasco M; Bermúdez V
    Am J Ther; 2010; 17(3):237-54. PubMed ID: 20479579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
    Gaddam KK; Oparil S
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renin inhibition in hypertension].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():15-22. PubMed ID: 20019472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
    Pimenta E; Oparil S
    Vasc Health Risk Manag; 2009; 5(1):453-63. PubMed ID: 19475781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renin and the heart].
    Ural D; Cetin M
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():23-7. PubMed ID: 20019473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal protection in the patients with idiopathic hypertensia: the possibilities of the combined blockade of the reninangiotensinaldosterone system].
    Kachnov VA; Tyrenko VV; Nikitin AÉ; Sinopal'nikov DO; Kol'tsov AV
    Voen Med Zh; 2010 Aug; 331(8):20-4. PubMed ID: 21089428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):115-28. PubMed ID: 21105865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN; Luft FC
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aliskiren in the treatment of hypertension and organ damage.
    Riccioni G
    Cardiovasc Ther; 2011 Feb; 29(1):77-87. PubMed ID: 21106033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
    Estacio RO
    Postgrad Med; 2009 May; 121(3):33-44. PubMed ID: 19491538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aliskiren: beyond blood pressure reduction.
    Riccioni G; Vitulano N; Zanasi A; Bellocci F; d'Orazio N
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1265-74. PubMed ID: 20812878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
    Sureshkumar KK
    Vasc Health Risk Manag; 2008; 4(6):1205-20. PubMed ID: 19337534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
    Siragy H; Huang J; Lieb DC
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):417-30. PubMed ID: 18764720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.